Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda

JH Oyugi, J Byakika-Tusiime, K Ragland… - Aids, 2007 - journals.lww.com
Objective: To evaluate adherence, treatment interruptions, and outcomes in patients
purchasing antiretroviral fixed-dose combination (FDC) therapy. Design: Ninety-seven …
被引用次数：351 相关文章

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda

JH Oyugi, J Byakika-Tusiime, K Ragland… - AIDS, 2007 - ohsu.elsevierpure.com
OBJECTIVE: To evaluate adherence, treatment interruptions, and outcomes in patients
purchasing antiretroviral fixed-dose combination (FDC) therapy. DESIGN: Ninety-seven …

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.

JH Oyugi, J Byakika-Tusiime, K Ragland… - AIDS (London …, 2007 - europepmc.org
Objective To evaluate adherence, treatment interruptions, and outcomes in patients
purchasing antiretroviral fixed-dose combination (FDC) therapy. Design Ninety-seven …

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda

JH Oyugi, J Byakika-Tusiime, K Ragland… - 2007 - dspace.mak.ac.ug
Objective: To evaluate adherence, treatment interruptions, and outcomes in patients
purchasing antiretroviral fixed-dose combination (FDC) therapy. Design: Ninety-seven …
[PDF] academia.edu

[PDF][PDF] Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda

JH Oyugi, J Byakika-Tusiime, K Ragland… - AIDS, 2007 - academia.edu
Objective: To evaluate adherence, treatment interruptions, and outcomes in patients
purchasing antiretroviral fixed-dose combination (FDC) therapy. Design: Ninety-seven …

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda

JH Oyugi, J Byakika-Tusiime, K Ragland… - AIDS, 2007 - journals.lww.com
Objective: To evaluate adherence, treatment interruptions, and outcomes in patients
purchasing antiretroviral fixed-dose combination (FDC) therapy. Design: Ninety-seven …

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.

JH Oyugi, J Byakika-Tusiime, K Ragland… - 2007 - cabidigitallibrary.org
Objective: To evaluate adherence, treatment interruptions, and outcomes in patients
purchasing antiretroviral fixed-dose combination (FDC) therapy. Design: Ninety-seven …

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda

JH Oyugi, J Byakika-Tusiime… - AIDS (London …, 2007 - pubmed.ncbi.nlm.nih.gov
Objective To evaluate adherence, treatment interruptions, and outcomes in patients
purchasing antiretroviral fixed-dose combination (FDC) therapy. Design Ninety-seven …

[引用][C] Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda …

JH OYUGI, J BYAKIKA-TUSIIME, R MURPHY… - AIDS …, 2007 - pascal-francis.inist.fr
Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose
combination antiretroviral therapy in Kampala, Uganda. Commentary CNRS Inist Pascal-Francis …

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda

JH Oyugi, J Byakika-Tusiime, K Ragland… - AIDS, 2007 - hero.epa.gov
Objective: To evaluate adherence, treatment interruptions, and outcomes in patients
purchasing antiretroviral fixed-dose combination (FDC) therapy. Design: Ninety-seven …